Andy Chevigné and his crew, RTI-5152-12 is postulated to boost the levels of opioid peptides that bind to classical opioid receptors from the brain, causing heightened painkilling activity. The LIH-RTI investigation teams founded a collaboration arrangement and filed a joint patent application in December 2020.Publishing this critique ensures that